Concepedia

Ying Cheng

YC

36

Publications

2.2K

Citations

22

H-Index

2011

Active since

Affiliations

Tianjin Medical University(Current)

Air Force Medical University

Second Military Medical University

Tianjin Infectious Diseases Hospital

Shanxi Medical University

Ying Cheng is an author at Tianjin Medical University specializing in medicine, cell biology, and radiation oncology.

ORCID

Top concepts

Publications per year

2011–2024

36

Publications

36

SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart

Chenguang Li, Jie Zhang, Mei Xue et al. · Cardiovascular Diabetology · 2019 · 560 citations · Full text

Mitochondria-targeted cyclosporin A delivery system to treat myocardial ischemia reperfusion injury of rats

Chang-xiong Zhang, Ying Cheng, Daozhou Liu et al. · Journal of Nanobiotechnology · 2019 · 215 citations · Full text

Triptolide Attenuates Renal Tubular Epithelial-mesenchymal Transition Via the MiR-188-5p-mediated PI3K/AKT Pathway in Diabetic Kidney Disease

Mei Xue, Ying Cheng, Fei Han et al. · International Journal of Biological Sciences · 2018 · 112 citations · Full text

Empagliflozin Attenuates Hyperuricemia by Upregulation of ABCG2 via AMPK/AKT/CREB Signaling Pathway in Type 2 Diabetic Mice

Yunhong Lu, Yunpeng Chang, Ting Li et al. · International Journal of Biological Sciences · 2020 · 111 citations · Full text

The SGLT2 inhibitor empagliflozin negatively regulates IL-17/IL-23 axis-mediated inflammatory responses in T2DM with NAFLD via the AMPK/mTOR/autophagy pathway

Ziyu Meng, Xiaohuan Liu, Ting Li et al. · International Immunopharmacology · 2021 · 108 citations

, , +10

Rows per page

1–5 of 36